Suppr超能文献

加拿大的汉坦病毒肺综合征:临床特征、诊断、流行病学及预防概述

Hantavirus pulmonary syndrome in Canada: An overview of clinical features, diagnostics, epidemiology and prevention.

作者信息

Drebot M A, Jones S, Grolla A, Safronetz D, Strong J E, Kobinger G, Lindsay R L

机构信息

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

出版信息

Can Commun Dis Rep. 2015 Jun 4;41(6):124-131. doi: 10.14745/ccdr.v41i06a02.

Abstract

Hantavirus pulmonary syndrome is a disease caused by the inhalation of excreta from infected deer mice. In Canada, the majority of hantavirus pulmonary syndrome cases occur in the western provinces of British Columbia, Alberta, Saskatchewan and Manitoba and the primary cause of the illness is the Sin Nombre virus. Only one case of hantavirus pulmonary syndrome has been documented in eastern Canada (Québec); however, Sin Nombre virus-infected deer mice have been identified across the country. Although cases are rare (yearly case numbers range from zero to 13 and the total number of confirmed cases in Canada now total 109), the mortality rate among infected individuals is approximately 30%. The majority of cases occur in the spring and early summer indicating seasonally-associated risk factors for viral exposure. In 2013 and 2014, a substantial increase in the number of hantavirus pulmonary syndrome cases was identified; however the cause remains unclear. No antivirals or vaccines are currently available and treatment is supportive. Public education, rodent control and the use of personal protective measures are key to avoid infections in at-risk populations.

摘要

汉坦病毒肺综合征是一种因吸入受感染鹿鼠的排泄物而引发的疾病。在加拿大,大多数汉坦病毒肺综合征病例发生在不列颠哥伦比亚省、艾伯塔省、萨斯喀彻温省和曼尼托巴省等西部省份,该疾病的主要病因是辛诺柏病毒。加拿大东部(魁北克省)仅记录到一例汉坦病毒肺综合征病例;然而,在全国各地均已发现感染辛诺柏病毒的鹿鼠。尽管病例罕见(每年病例数从0至13例不等,加拿大目前确诊病例总数为109例),但感染者的死亡率约为30%。大多数病例发生在春季和初夏,这表明存在与季节相关的病毒暴露风险因素。2013年和2014年,汉坦病毒肺综合征病例数量大幅增加;然而,病因仍不清楚。目前尚无抗病毒药物或疫苗,治疗以支持性治疗为主。公众教育、灭鼠以及采取个人防护措施是避免高危人群感染的关键。

相似文献

8
Hantavirus pulmonary syndrome in Manitoba.曼尼托巴省的汉坦病毒肺综合征
Can J Infect Dis. 2001 May;12(3):169-73. doi: 10.1155/2001/425260.

引用本文的文献

1
Achievement and Challenges in Orthohantavirus Vaccines.正汉坦病毒疫苗的成就与挑战
Vaccines (Basel). 2025 Feb 17;13(2):198. doi: 10.3390/vaccines13020198.
5
Hantavirus Cardiopulmonary Syndrome in Canada.加拿大汉坦病毒心肺综合征。
Emerg Infect Dis. 2020 Dec;26(12):3020-3024. doi: 10.3201/eid2612.202808.
6
Biodefense Implications of New-World Hantaviruses.新大陆汉坦病毒的生物防御意义
Front Bioeng Biotechnol. 2020 Aug 7;8:925. doi: 10.3389/fbioe.2020.00925. eCollection 2020.

本文引用的文献

1
Hantaviruses--globally emerging pathogens.汉坦病毒——全球范围内新出现的病原体。
J Clin Virol. 2015 Mar;64:128-36. doi: 10.1016/j.jcv.2014.08.033. Epub 2014 Oct 20.
4
Hantaviruses and cardiopulmonary syndrome in South America.南美洲的汉坦病毒与心肺综合征
Virus Res. 2014 Jul 17;187:43-54. doi: 10.1016/j.virusres.2014.01.015. Epub 2014 Feb 5.
9
Ecology of hantaviruses and their hosts in North America.北美的汉坦病毒及其宿主的生态学
Vector Borne Zoonotic Dis. 2010 Aug;10(6):563-74. doi: 10.1089/vbz.2009.0018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验